المؤلفون: Quintela-Fandino M, Lluch A, Manso L, Calvo I, Cortes J, García-Saenz JA, Gil-Gil M, Martinez-Jánez N, Gonzalez-Martin A, Adrover E, de Andres R, Viñas G, Llombart-Cussac A, Alba E, Guerra J, Bermejo B, Zamora E, Moreno-Anton F, Pernas Simon S, Carrato A, Lopez-Alonso A, Escudero MJ, Campo R, Carrasco E, Palacios J, Mulero F, Colomer R

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname

URL الوصول: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::28a38bf10c6ca3a3f81e511cb5502823
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=2200

المؤلفون: Llombart-Cussac A, Ramos M, Dalmau E, García-Saenz JA, González-Farré X, Murillo L, Calvo L, Morales S, Carañana V, González A, Fernández-Morales LA, Moreno F, Casas MI, Angulo Mdel M, Cámara MC, Garcia-Mace AI, Carrasco E, Jara-Sánchez C

المصدر: EUROPEAN JOURNAL OF CANCER
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica
instname

مصطلحات موضوعية: Antiemesis, Docetaxel-cyclophosphamide, CINV, Early breast cancer, Aprepitant

URL الوصول: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::8a292c8ce05765d5643a3db91aeb57c0
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=1630

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Llombart-Cussac A, Ruiz A, Antón A, Barnadas A, Antolín S, Alés-Martínez JE, Alvarez I, Andrés R, García Saenz JA, Lao J, Carrasco E, Cámara C, Casas I, Martín M, Llombart-Cussac, Antonio, Ruiz, Amparo, Antón, Antonio, Barnadas, Agustí, Antolín, Silvia, Alés-Martínez, José E

المصدر: Cancer (0008543X); Jan2012, Vol. 118 Issue 1, p241-247, 7p

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Martin M; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón Instituto de Investigacion Sanitaria Gregorio Marañon (IiSGM), CIBERONC, Universidad Complutense, Dr Esquerdo 46, 28007, Madrid, Spain. mmartin@geicam.org., Ramos-Medina R; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC, Madrid, Spain., Bernat R; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC, Madrid, Spain., García-Saenz JA; Department of Medical Oncology, Hospital Clínico San Carlos, CIBERONC, Madrid, Spain., Del Monte-Millan M; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC, Madrid, Spain., Alvarez E; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC, Madrid, Spain., Cebollero M; Department of Pathology, Hospital General Universitario Gregorio Marañón, Madrid, Spain., Moreno F; Department of Medical Oncology, Hospital Clínico San Carlos, CIBERONC, Madrid, Spain., Gonzalez-Haba E; Pharmacy Department, Hospital Universitario Gregorio Marañón, Madrid, Spain., Bueno O; Radiodiagnosis Department, Hospital General Universitario Gregorio Marañón, IiSGM, Madrid, Spain., Romero P; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC, Madrid, Spain., Massarrah T; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC, Madrid, Spain., Echavarria I; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón Instituto de Investigacion Sanitaria Gregorio Marañon (IiSGM), CIBERONC, Universidad Complutense, Dr Esquerdo 46, 28007, Madrid, Spain., Jerez Y; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón Instituto de Investigacion Sanitaria Gregorio Marañon (IiSGM), CIBERONC, Universidad Complutense, Dr Esquerdo 46, 28007, Madrid, Spain., Herrero B; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón Instituto de Investigacion Sanitaria Gregorio Marañon (IiSGM), CIBERONC, Universidad Complutense, Dr Esquerdo 46, 28007, Madrid, Spain., Gonzalez Del Val R; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón Instituto de Investigacion Sanitaria Gregorio Marañon (IiSGM), CIBERONC, Universidad Complutense, Dr Esquerdo 46, 28007, Madrid, Spain., Lobato N; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC, Madrid, Spain., Rincon P; Gynecology Department, Hospital General Universitario Gregorio Marañón, IiSGM, Universidad Complutense, Madrid, Spain., Palomero MI; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón Instituto de Investigacion Sanitaria Gregorio Marañon (IiSGM), CIBERONC, Universidad Complutense, Dr Esquerdo 46, 28007, Madrid, Spain., Marquez-Rodas I; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón Instituto de Investigacion Sanitaria Gregorio Marañon (IiSGM), CIBERONC, Universidad Complutense, Dr Esquerdo 46, 28007, Madrid, Spain., Lizarraga S; Gynecology Department, Hospital General Universitario Gregorio Marañón, IiSGM, Universidad Complutense, Madrid, Spain., Asensio F; Experimental Medicine and SurgeryUnit, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain., Lopez-Tarruella S; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón Instituto de Investigacion Sanitaria Gregorio Marañon (IiSGM), CIBERONC, Universidad Complutense, Dr Esquerdo 46, 28007, Madrid, Spain.

المصدر: Scientific reports [Sci Rep] 2021 Mar 29; Vol. 11 (1), pp. 7064. Date of Electronic Publication: 2021 Mar 29.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Triple Negative Breast Neoplasms/*drug therapy, Animals ; Carboplatin/administration & dosage ; Docetaxel/administration & dosage ; Doxorubicin/administration & dosage ; Female ; Humans ; Xenograft Model Antitumor Assays

المؤلفون: Ruiz-Pinto S; Human Genotyping Unit-Centro Nacional de Genotipado (CEGEN), Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Pita G; Human Genotyping Unit-Centro Nacional de Genotipado (CEGEN), Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Martín M; Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain., Nuñez-Torres R; Human Genotyping Unit-Centro Nacional de Genotipado (CEGEN), Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Cuadrado A; Chromosome Dynamics Group. Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Shahbazi MN; Epithelial Cell Biology Group, Cancer Cell Biology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK., Caronia D; Human Genotyping Unit-Centro Nacional de Genotipado (CEGEN), Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Kojic A; Chromosome Dynamics Group. Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Moreno LT; Human Genotyping Unit-Centro Nacional de Genotipado (CEGEN), Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., de la Torre-Montero JC; San Juan de Dios School of Nursing and Physical Therapy, Comillas Pontifical University, Madrid, Spain.; Medical Oncology Service, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Hospital Clínico San Carlos, Madrid, Spain., Lozano M; Laboratory and Research Divison, Taper, Madrid, Spain., López-Fernández LA; Pharmacy Department, Laboratory of Pharmacogenomics, Instituto de Investigación Sanitaria Gregorio Marañón, Hospital General Universitario Gregorio Marañón, Madrid, Spain., Ribelles N; UGC Oncología Intercentros, Institute of Biomedical Research in Malaga (IBIMA), Hospitales Universitarios Regional y Virgen de la Victoria de Málaga, Malaga, Spain., García-Saenz JA; Medical Oncology Service, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Hospital Clínico San Carlos, Madrid, Spain., Alba E; UGC Oncología Intercentros, Institute of Biomedical Research in Malaga (IBIMA), Hospitales Universitarios Regional y Virgen de la Victoria de Málaga, Malaga, Spain., Milne RL; Cancer Epidemiology & Intelligence Division, Cancer Council Victoria, Melbourne, Victoria, Australia.; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia., Losada A; Chromosome Dynamics Group. Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Pérez-Moreno M; Epithelial Cell Biology Group, Cancer Cell Biology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Benítez J; Human Genetics Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., González-Neira A; Human Genotyping Unit-Centro Nacional de Genotipado (CEGEN), Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.

المصدر: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2021 Feb; Vol. 109 (2), pp. 462-470. Date of Electronic Publication: 2020 Sep 18.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE

مواضيع طبية MeSH: Antimetabolites, Antineoplastic/*adverse effects , Cadherins/*genetics , Capecitabine/*adverse effects , Hand-Foot Syndrome/*etiology , Hand-Foot Syndrome/*genetics , Polymorphism, Single Nucleotide/*genetics, Adult ; Aged ; Aged, 80 and over ; Antimetabolites, Antineoplastic/therapeutic use ; Capecitabine/therapeutic use ; Cell Line ; Female ; Genetic Predisposition to Disease/genetics ; Haplotypes/genetics ; Humans ; Keratinocytes/drug effects ; Male ; Middle Aged ; Neoplasms/drug therapy ; Neoplasms/genetics ; Promoter Regions, Genetic/genetics ; Risk

المؤلفون: Picornell AC; Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Doctor Esquerdo 46, 28007, Madrid, Spain. antonio.picornell@iisgm.com., Echavarria I; Hospital General Universitario Gregorio Marañón, Madrid, Spain., Alvarez E; Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Doctor Esquerdo 46, 28007, Madrid, Spain., López-Tarruella S; Medical Oncology Service, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM). CiberOnc, Hospital General Universitario Gregorio Marañón, Madrid, Spain., Jerez Y; Medical Oncology Service, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM). CiberOnc, Hospital General Universitario Gregorio Marañón, Madrid, Spain., Hoadley K; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Parker JS; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Del Monte-Millán M; Medical Oncology Service, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM). CiberOnc, Hospital General Universitario Gregorio Marañón, Madrid, Spain., Ramos-Medina R; Medical Oncology Service, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM). CiberOnc, Hospital General Universitario Gregorio Marañón, Madrid, Spain., Gayarre J; Medical Oncology Service, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM). CiberOnc, Hospital General Universitario Gregorio Marañón, Madrid, Spain., Ocaña I; Medical Oncology Service, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM). CiberOnc, Hospital General Universitario Gregorio Marañón, Madrid, Spain., Cebollero M; Anatomical Pathology Service, Hospital General Universitario Gregorio Marañón, Madrid, Spain., Massarrah T; Medical Oncology Service, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM). CiberOnc, Hospital General Universitario Gregorio Marañón, Madrid, Spain., Moreno F; Medical Oncology Service, Hospital Universitario Clínico San Carlos, Madrid, Spain., García Saenz JA; Medical Oncology Service, Hospital Universitario Clínico San Carlos, Madrid, Spain., Gómez Moreno H; Medicina Oncológic, Instituto Nacional de Enfermedades Neoplásicas (INEN), Lima, Peru., Ballesteros A; Medical Oncology Service, Hospital Universitario de La Princesa, Madrid, Spain., Ruiz Borrego M; Hospital Virgen del Rocío, Sevilla, Spain., Perou CM; Department of Genetics, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA., Martin M; Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Universidad Complutense, CiberOnc, GEICAM, Madrid, Spain.

المصدر: BMC genomics [BMC Genomics] 2019 Jun 03; Vol. 20 (1), pp. 452. Date of Electronic Publication: 2019 Jun 03.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100965258 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2164 (Electronic) Linking ISSN: 14712164 NLM ISO Abbreviation: BMC Genomics Subsets: MEDLINE

مواضيع طبية MeSH: Biomarkers, Tumor/*genetics , Gene Expression Profiling/*methods , High-Throughput Nucleotide Sequencing/*methods , Neoplasm Recurrence, Local/*genetics , Triple Negative Breast Neoplasms/*genetics, Female ; Follow-Up Studies ; Gene Expression Regulation, Neoplastic ; Humans ; Neoplasm Recurrence, Local/pathology ; Prognosis ; Prospective Studies ; Triple Negative Breast Neoplasms/pathology